Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Huawei Investment and Holding Co Ltd | 3,172 |
| 2 | Intel Corp | 1,089 |
| 3 | Everpure Inc | 725 |
| 4 | Samsung Electronics Co Ltd | 709 |
| 5 | Telefonaktiebolaget LM Ericsson AB | 681 |
| 6 | JPMorgan Chase and Co | 599 |
| 7 | Apple Inc | 582 |
| 8 | Amazon.com Inc | 534 |
| 9 | Microsoft Corp | 530 |
| 10 | China Mobile Communications Group Co Ltd | 503 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | H04L | 28,294 | |
| 2 | G06F | 13,767 | |
| 3 | H04W | 11,567 | |
| 4 | A61K | Medicinal preparations | 6,178 |
| 5 | A61P | Therapeutic activity (drug indications) | 5,789 |
| 6 | C12N | Microorganisms, enzymes | 5,004 |
| 7 | Y02D | 4,424 | |
| 8 | H04N | 4,149 | |
| 9 | G06Q | 3,542 | |
| 10 | G06N | 3,253 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Method of treating lung diseases with uridine 5'-diphosphate and analogs thereof | 2000 | Akorn Operating Co LLC | 59 |
| Uridine 5'-diphosphate and analogs useful for treating lung diseases | 2000 | Akorn Operating Co LLC | 58 |
| Method of treating lung diseases with uridine 5′-diphosphate and analogs thereof | 2002 | Akorn Operating Co LLC | 32 |
| URIDINE DIPHOSPHATE DERIVATIVES, COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS | 2013 | 26 | |
| URIDINE DIPHOSPHATE DERIVATIVES, PRODRUGS, COMPOSITIONS AND USES THEREOF | 2014 | 15 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 34 |
| 2017 | 26 |
| 2018 | 26 |
| 2019 | 18 |
| 2020 | 31 |
| 2021 | 35 |
| 2022 | 143 |
| 2023 | 123 |
| 2024 | 48 |
| 2025 | 2 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Todd L. Lowary | University of Alberta | 9 |
| 2 | Martin E. Tanner | University of British Columbia | 7 |
| 3 | John O. Miners | Flinders University | 6 |
| 4 | Perry A. Frey | University of Wisconsin–Madison | 6 |
| 5 | Bernard Robaye | Université Libre de Bruxelles | 6 |
| 6 | Eduardo R. Lazarowski | University of North Carolina at Chapel Hill | 6 |
| 7 | David Erlinge | Lund University | 6 |
| 8 | Kenneth A. Jacobson | National Institute of Diabetes and Digestive and Kidney Diseases | 6 |
| 9 | Richard C. Boucher | University of North Carolina at Chapel Hill | 5 |
| 10 | G.J. Davies | University of York | 5 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis | 2007 | 816 | Adenosine and Purinergic Signaling |
| The Arabidopsis UDP‐glycosyltransferases UGT79B2 and UGT79B3, contribute to cold, salt and drought stress tolerance via modulating anthocyanin accumulation | 2016 | 607 | Photosynthetic Processes and Mechanisms |
| A little sugar goes a long way: The cell biology of O-GlcNAc | 2015 | 586 | Glycosylation and Glycoproteins Research |
| Higher plant glycosyltransferases. | 2001 | 517 | Plant tissue culture and regeneration |
| Structure of a flavonoid glucosyltransferase reveals the basis for plant natural product modification | 2006 | 471 | Microbial Natural Products and Biosynthesis |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of Uridine Diphosphate?
What are the major research areas associated with Uridine Diphosphate based on published papers?
What therapeutic applications of Uridine Diphosphate are documented in the patent literature?
Which researchers have published the most papers on topics related to Uridine Diphosphate?
What is the recent trend in patent and publication activity related to Uridine Diphosphate?